Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.2044
Abstract: Importance Although isotretinoin may rarely be associated with laboratory abnormalities such as hypertriglyceridemia, the optimal approach to laboratory monitoring is uncertain, and there is wide variation in clinical practice. Objective To establish a consensus for… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Platelets"
DOI: 10.1016/b978-0-12-813456-6.00036-9
Abstract: Abstract The response to antiplatelet therapy varies from one patient to another. While high on-treatment residual platelet reactivity (HRPR) as assessed by established methods represents an independent risk factor for ischemic events following percutaneous coronary… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "American Heart Journal"
DOI: 10.1016/j.ahj.2017.10.002
Abstract: &NA; The novel direct oral anticoagulants (NOACs) represent a major advance in oral anticoagulant therapy and are replacing vitamin K antagonists as the preferred options for many indications. Given in fixed doses without routine laboratory… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of child and adolescent psychopharmacology"
DOI: 10.1089/cap.2020.0096
Abstract: Objectives: The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guidelines provide monitoring recommendations for children who are treated with second-generation antipsychotics (SGAs). The objective of this study was to determine… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqy151
Abstract: OBJECTIVES To review the use of laboratory tests for antiplatelet agents to determine escalation of antiplatelet therapy and for emergent reversal of P2Y12 inhibitors. METHODS A case scenario and review of cardiovascular and neurointerventional literature… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaa439.819
Abstract: OPAT helps reduce hospital length of stay, but 1 in 4 patients is readmitted within 30 days of discharge. Follow up < 30 days after discharge and laboratory monitoring during therapy have been shown to… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-141310
Abstract: BACKGROUND The COVID-19 pandemic has extensively impacted the delivery of routine medical care including anticoagulation management. The Veterans Affairs Clinical Pharmacy Practice Office (VA CPPO) has provided guidance to assist anticoagulation clinic providers in developing… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Blood advances"
DOI: 10.1182/bloodadvances.2019000849
Abstract: Monitoring factor VIII (FVIII) activity has traditionally been complicated by discrepancies between assays for the various sorts of FVIII molecules. The advent of novel nonfactor therapies (emicizumab, fitusiran, and anti-tissue factor pathway inhibitor antibodies) in… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Clinical journal of oncology nursing"
DOI: 10.1188/22.cjon.487-494
Abstract: BACKGROUND There are many inefficiencies related to oral chemotherapy (OC) laboratory monitoring and follow-up in the ambulatory clinic setting. Patients with cancer prescribed OC have a higher risk of adverse events when there is inconsistent… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2020.40.2.101
Abstract: Biological drugs, such as proteins and immunogens, are increasingly used to treat various diseases, including tumors and autoimmune diseases, and biological molecules have almost completely replaced synthetic drugs in rheumatology. Although biological treatments such as… read more here.